Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleOriginal Research

The Role of Ultrasound in Research and Clinical Practice in Psoriatic Arthritis: Highlights From the GRAPPA Ultrasound Workshop

Lihi Eder, Sibel Z. Aydin and Gurjit S. Kaeley
The Journal of Rheumatology Supplement June 2021, 97 55-57; DOI: https://doi.org/10.3899/jrheum.201677
Lihi Eder
1L. Eder, MD, PhD, Assistant Professor of Medicine, University of Toronto and Women’s College Hospital, Toronto, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lihi Eder
  • For correspondence: lihi.eder@wchospital.ca
Sibel Z. Aydin
2S.Z. Aydin, MD, Associate Professor of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sibel Z. Aydin
Gurjit S. Kaeley
3G.S. Kaeley, MD, MBBS, MRCP, RhMSUS, Professor of Medicine, University of Florida College of Medicine, Jacksonville, Florida, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gurjit S. Kaeley
  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Abstract

Ultrasound (US) is a valuable imaging modality that can accurately identify relevant features of psoriatic arthritis (PsA), such as synovitis, tenosynovitis, and enthesitis. The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Ultrasound Committee ran a workshop during the annual GRAPPA meeting that was held in July 2020. The group presented the following 3 topics: (1) the transition from psoriasis to PsA and the role of US; (2) the effect of biomechanical forces on the entheses in health and disease, and insight for PsA pathogenesis; and (3) differentiation of enthesitis from pain sensitization: use and limitations of clinical and sonographic evaluation of enthesitis. This article summarizes the key messages from this workshop.

Key Indexing Terms:
  • GRAPPA
  • psoriasis
  • psoriatic arthritis
  • ultrasound

The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Ultrasound Committee, led by Lihi Eder, Sibel Aydin, and Gurjit Kaeley, had a live ultrasound (US) workshop during the annual GRAPPA meeting held virtually in July 2020. With 82 participants, the workshop was one of the most attended sessions during the annual meeting. The group presented 3 topics: (1) the transition from psoriasis (PsO) to psoriatic arthritis (PsA) and the role of US; (2) the effect of biomechanical forces on the entheses in health and disease, and insight for PsA pathogenesis; and (3) differentiation of enthesitis from pain sensitization: use and limitations of clinical and sonographic evaluation of enthesitis.

The Transition of PsO to PsA

The first topic presented in the workshop by Lihi Eder was the role of musculoskeletal (MSK) US in studying the transition from PsO to PsA. The possibility of PsA prevention has recently gained attention with the advent of effective targeted treatments for PsO. However, since the annual conversion of PsO to PsA remains low, it is important to identify high-risk individuals that can be the target of such interventional trials. US can identify relevant abnormalities, such as enthesitis, synovitis, and tenosynovitis among patients with PsO who do not have any MSK symptoms. A significant proportion of patients with PsO have subclinical enthesitis and synovitis.1,2 Similar to findings in other rheumatic diseases such as rheumatoid arthritis and systemic lupus erythematosus, these findings suggest that the inflammatory process is initiated prior to the development of MSK symptoms and may provide a window of opportunity for early intervention. Emerging evidence from 2 small prospective cohort studies suggest that such subclinical sonographic inflammatory findings are associated with a higher risk of future development of PsA, especially when they occur with MSK symptoms.2,3 Moreover, another recent study showed that treatment of subclinical sonographic enthesitis with targeted biologic therapy resulted in a reduction of enthesitis activity, highlighting the reversibility of inflammation and raising the possibility of prevention of PsA using effective therapies in high-risk patients.4

In addition, MSK US could potentially help the rheumatologist diagnose PsA earlier. Recent studies showed that many patients with PsA develop nonspecific MSK symptoms several years prior to the diagnosis of the disease.5 In the absence of overt findings on physical examination, US holds a significant potential to establish an earlier diagnosis of PsA. In a rapid access clinic, 48% of the patients with PsO who presented with MSK symptoms and were thought not to have PsA after a rheumatologist assessment were found to have at least 1 site with active inflammation by US (joint or enthesis with positive Doppler signal).6 Overall, these data highlight the potential role of US in identifying patients with PsO at high risk for PsA who can be potential candidates for interventional trials, as well as support the use of US at the point of care to optimize earlier diagnosis of PsA.

The Effect of Biomechanical Forces on the Entheses in Health and Disease

The second workshop topic was presented by Sibel Aydin and was on the effect of biomechanical forces on the entheses and insights for PsA pathogenesis. Three recent studies specifically looked at the entheseal changes detected by US and described frequencies and/or severity of the elementary lesions, as well as factors leading to these changes.7,8,9 The entheses are continuously exposed to biomechanical forces during daily activities, causing increased changes in the echogenicity and increased vascularity, as shown with the presence of Doppler signals. In addition to these inflammatory changes, abnormalities of the bone profile, such as bony spurs at the insertions (enthesophytes), are also very common in the general population. Increased age, higher BMI, male sex, and higher intensity physical activities are associated with these inflammatory and physical damage signs.7 Understanding the changes within the enthesis is important for 2 reasons. First, it is important to understand what is normal and acceptable in different demographic groups. This information is crucial so that enthesitis due to spondyloarthropathy (SpA) is not over diagnosed using US. The second reason is to explain the pathogenesis of SpA. The defense mechanisms within the entheses may be the key to understand what fails in SpA and whether these are the initial steps pulling the trigger. After reviewing the evidence during the workshop, the participants discussed how they approached entheseal findings clinically. There was a consensus that there is not one finding leading to a diagnosis of SpA/PsA, despite the Doppler signals and erosions being relatively more specific to the disease state. The participants declared they usually seek a combination of these findings. Also, another clue is that patients with SpA generally have more than one entheseal site, whereas healthy people generally have only one site. Overall, there is not a fixed definition of inflammatory enthesitis using US yet and entheseal findings still need to be interpreted by an expert, taking into consideration the patients’ age, BMI, sex, and physical activity, as well as other clinical findings.

Differentiation of Enthesitis From Pain Sensitization: Use and Limitations of Clinical and Sonographic Evaluation of Enthesitis

Gurjit Kaeley presented the third topic, which addressed the use and limitations of entheses US to differentiate enthesitis from pain sensitization in subjects with PsA. Fibromyalgia (FM) is a common problem encountered by rheumatologists. Pain is its hallmark with coexisting somatic symptoms such as fatigue, sleep disturbance, and impaired cognition. The prevalence of FM and PsA is estimated to be between 15-25%.10,11 “The classification criteria for FM have increasingly recognized the importance of somatic symptoms. The 2010 American College of Rheumatology classification criteria used the widespread pain index and somatic scores to classify subjects with FM instead of widespread pain and tender points used in the 1990 classification criteria.12,13 Notably, the 1990 FM tender points are at or near entheseal sites that are used to assess disease activity in PsA. Therefore, entheseal examination is clinically subject to pain sensitization. Subjects with coexisting PsA and FM report a higher disease activity, worse functional deficit, and are less likely to achieve minimal disease activity than patients with PsA or FM alone.10,11 The prevalence of both FM and obesity increases with age, and may result in a higher prevalence of degenerative changes and associated pain.

Marchesoni, et al suggested that patients with FM could be distinguished from those with PsA when > 6 FM-associated symptoms and > 8 tender points were present.14 An imaging substudy from the same cohort examined 7 pairs of entheses and found that the classification of more than 3 involved sites had 72% sensitivity and 76% specificity to predict PsA.15 Macchioni, et al compared patients with PsA, PsO, and FM, and found that clinical enthesitis median scores were highest in the FM group.16 In contrast, B-mode and Doppler sonographic findings were higher in the PsA and PsO groups compared to the FM patients. The FM group was imbalanced with a much higher number of females and a lower BMI.16 The clinical conundrum often facing the practitioner is distinguishing the source of pain in a PsA patient from uncontrolled disease activity vs regional pain and central pain sensitization.

Fiorenza, et al compared patients with FM only, PsA only, and patients with both PsA with FM.17 As seen in previous studies, clinical enthesitis scores were highest in FM patients, followed by FM patients with PsA. Entheseal evaluation using the Glasgow Ultrasound Enthesitis Scoring System (GUESS) distinguished the PsA groups from the FM group. However, PsA alone or PsA with FM could not be differentiated. An intriguing recent study by Martinis, et al suggested that the GUESS scoring system may not distinguish inflammatory bowel disease (IBD)-related SpA patients with or without FM.18 The Madrid Sonography Enthesitis Index, which includes 1 upper extremity enthesis site and incorporates Doppler findings, was able to discriminate patients with IBD-related SpA from those with IBD and FM.

In summary, US using indices such as GUESS does not distinguish active enthesitis from pain sensitization in patients with PsA. Polling of workshop participants indicated that the majority scanned clinically painful areas, whereas others also included standard lower extremity entheses and hand entheses. Further studies with a choice of entheses that limit biomechanical confounders are warranted.

Conclusion

Overall, these topics triggered interactive discussions regarding the role of US in rheumatology and dermatology practice. During the panel discussion part, the group conducted a poll to inform future directions of the GRAPPA Ultrasound Working Group. Most participants were interested in research aimed at developing a prediction model for PsA and, in second place, in studies that assessed the effect of point-of-care US on PsA outcomes (e.g., early diagnosis, achieving remission). This feedback will guide the development of the research agenda by the US working group.

Footnotes

  • As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards.

  • LE, SZA, and GSK have no conflicts of interest.

  • This paper does not require institutional review board approval.

  • Copyright © 2021 by The Journal of Rheumatology

References

  1. 1.↵
    1. Eder L,
    2. Jayakar J,
    3. Thavaneswaran A,
    4. Haddad A,
    5. Chandran V,
    6. Salonen D, et al
    . Is the MAdrid Sonographic Enthesitis Index useful for differentiating psoriatic arthritis from psoriasis alone and healthy controls? J Rheumatol 2014;41:466–72.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Zabotti A,
    2. McGonagle DG,
    3. Giovannini I,
    4. Errichetti E,
    5. Zuliani F,
    6. Zanetti A, et al
    . Transition phase towards psoriatic arthritis: clinical and ultrasonographic characterisation of psoriatic arthralgia. RMD Open 2019;5:e001067.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Elnady B,
    2. El Shaarawy NK,
    3. Dawoud NM,
    4. Elkhouly T,
    5. Desouky DE,
    6. ElShafey EN, et al
    . Subclinical synovitis and enthesitis in psoriasis patients and controls by ultrasonography in Saudi Arabia; incidence of psoriatic arthritis during two years. Clin Rheumatol 2019;38:1627–35.
    OpenUrl
  4. 4.↵
    1. Savage L,
    2. Goodfield M,
    3. Horton L,
    4. Watad A,
    5. Hensor E,
    6. Emery P, et al
    . Regression of peripheral subclinical enthesopathy in therapy-naive patients treated with ustekinumab for moderate-to-severe chronic plaque psoriasis: a fifty-two-week, prospective, open-label feasibility study. Arthritis Rheumatol 2019;71:626–31.
    OpenUrl
  5. 5.↵
    1. Eder L,
    2. Polachek A,
    3. Rosen CF,
    4. Chandran V,
    5. Cook R,
    6. Gladman DD
    . The development of psoriatic arthritis in patients with psoriasis is preceded by a period of nonspecific musculoskeletal symptoms: a prospective cohort study. Arthritis Rheumatol 2017;69:622–9.
    OpenUrl
  6. 6.↵
    1. Sarabia S,
    2. Farrer C,
    3. Yeung J,
    4. Jerome D,
    5. Lee KA,
    6. Cook R, et al
    . The pattern of musculoskeletal complaints in patients with suspected psoriatic arthritis and their correlation with physical examination and ultrasound. J Rheumatol 2020 May 15 (E-pub ahead of print).
  7. 7.↵
    1. Bakirci S,
    2. Solmaz D,
    3. Stephenson W,
    4. Eder L,
    5. Roth J,
    6. Aydin SZ
    . Entheseal changes in response to age, body mass index, and physical activity: an ultrasound study in healthy people. J Rheumatol 2020;47:968–72.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Di Matteo A,
    2. Filippucci E,
    3. Cipolletta E,
    4. Martire V,
    5. Jesus D,
    6. Musca A, et al
    . How normal is the enthesis by ultrasound in healthy subjects? Clin Exp Rheumatol 2020;38:472–8.
    OpenUrl
  9. 9.↵
    1. Guldberg-Møller J,
    2. Terslev L,
    3. Nielsen SM,
    4. Konig MJ,
    5. Torp-Pedersen ST,
    6. Torp-Pedersen A, et al
    . Ultrasound pathology of the entheses in an age and gender stratified sample of healthy adult subjects: a prospective cross-sectional frequency study. Clin Exp Rheumatol 2019;37:408–13.
    OpenUrl
  10. 10.↵
    1. Mease PJ
    . Fibromyalgia, a missed comorbidity in spondyloarthritis: prevalence and impact on assessment and treatment. Curr Opin Rheumatol 2017;29:304–10.
    OpenUrl
  11. 11.↵
    1. Zhao SS,
    2. Duffield SJ,
    3. Goodson NJ
    . The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis. Best Pract Res Clin Rheumatol 2019;33:101423.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Wolfe F,
    2. Smythe HA,
    3. Yunus MB,
    4. Bennett RM,
    5. Bombardier C,
    6. Goldenberg DL, et al
    . The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheumatol 1990; 33:160–72.
    OpenUrl
  13. 13.↵
    1. Wolfe F,
    2. Clauw DJ,
    3. Fitzcharles M-A,
    4. Goldenberg DL,
    5. Katz RS,
    6. Mease P, et al
    . The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010;62:600–10.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Marchesoni A,
    2. Atzeni F,
    3. Spadaro A,
    4. Lubrano E,
    5. Provenzano G,
    6. Cauli A, et al
    . Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia. J Rheumatol 2012;39:849–55.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Marchesoni A,
    2. De Lucia O,
    3. Rotunno L,
    4. De Marco G,
    5. Manara M
    . Entheseal Power doppler ultrasonography: a comparison of psoriatic arthritis and fibromyalgia. J Rheumatol Suppl 2012;89:29–31.
    OpenUrl
  16. 16.↵
    1. Macchioni P,
    2. Salvarani C,
    3. Possemato N,
    4. Gutierrez M,
    5. Grassi W,
    6. Gasparini S, et al
    . Ultrasonographic and clinical assessment of peripheral enthesitis in patients with psoriatic arthritis, psoriasis, and fibromyalgia syndrome: the ULISSE Study. J Rheumatol 2019;46:904–11.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Fiorenza A,
    2. Bonitta G,
    3. Gerratana E,
    4. Marino F,
    5. Sarzi-Puttini P,
    6. Salaffi F, et al
    . Assessment of enthesis in patients with psoriatic arthritis and fibromyalgia using clinical examination and ultrasound. Clin Exp Rheumatol 2020;38 Suppl 123:31–9.
    OpenUrl
  18. 18.↵
    1. Martinis F,
    2. Tinazzi I,
    3. Bertolini E,
    4. Citriniti G,
    5. Variola A,
    6. Geccherle A, et al
    . Clinical and sonographic discrimination between fibromyalgia and spondyloarthopathy in inflammatory bowel disease with musculoskeletal pain. Rheumatol 2020;59:2857–63.
    OpenUrl
PreviousNext
Back to top

In this issue

The Journal of Rheumatology Supplement
Vol. 97
1 Jun 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Role of Ultrasound in Research and Clinical Practice in Psoriatic Arthritis: Highlights From the GRAPPA Ultrasound Workshop
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Role of Ultrasound in Research and Clinical Practice in Psoriatic Arthritis: Highlights From the GRAPPA Ultrasound Workshop
Lihi Eder, Sibel Z. Aydin, Gurjit S. Kaeley
The Journal of Rheumatology Supplement Jun 2021, 97 55-57; DOI: 10.3899/jrheum.201677

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
The Role of Ultrasound in Research and Clinical Practice in Psoriatic Arthritis: Highlights From the GRAPPA Ultrasound Workshop
Lihi Eder, Sibel Z. Aydin, Gurjit S. Kaeley
The Journal of Rheumatology Supplement Jun 2021, 97 55-57; DOI: 10.3899/jrheum.201677
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • The Transition of PsO to PsA
    • The Effect of Biomechanical Forces on the Entheses in Health and Disease
    • Differentiation of Enthesitis From Pain Sensitization: Use and Limitations of Clinical and Sonographic Evaluation of Enthesitis
    • Conclusion
    • Footnotes
    • References
  • Info & Metrics
  • References
  • PDF
  • eLetters

Keywords

GRAPPA
PSORIASIS
PSORIATIC ARTHRITIS
ULTRASOUND

Related Articles

Cited By...

More in this TOC Section

  • Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) Meeting
  • Janus Kinase Inhibitors: Safety in Patients With Psoriatic Arthritis
  • Promoting Diversity, Equity, and Inclusion for Psoriatic Diseases
Show more Original Research

Similar Articles

Keywords

  • GRAPPA
  • psoriasis
  • psoriatic arthritis
  • ultrasound

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire